Inter-pregnancy interval and later pediatric cardiovascular health of the offspring - a population-based cohort study

Majdi Imterat1, Tamar Wainstock2, Eyal Sheiner1

  • 1Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

Short or long interpregnancy intervals (IPI) do not increase offspring cardiovascular hospitalizations. This study found no long-term cardiovascular risks for children born after extreme interpregnancy intervals.

Area of Science:

  • Reproductive Medicine and Perinatal Health
  • Cardiovascular Epidemiology
  • Pediatric Health Outcomes

Background:

  • Interpregnancy interval (IPI), the time between live birth and subsequent conception, is linked to short-term perinatal risks.
  • The long-term impact of extreme IPIs (short <6 months, long >60 months) on offspring cardiovascular health remains less understood.

Purpose of the Study:

  • To investigate the association between short and long interpregnancy intervals and long-term cardiovascular morbidity in offspring.
  • To determine if extreme IPIs are independent risk factors for pediatric cardiovascular hospitalizations.

Main Methods:

  • Population-based cohort study including singleton live births with at least one prior birth.
  • Evaluation of offspring hospitalizations for cardiovascular diseases up to age 18, categorized by IPI length (short, intermediate, long).
  • Kaplan-Meier survival analysis and Cox proportional hazards modeling to assess cumulative incidence and control for confounders.

Main Results:

  • A total of 161,793 deliveries were analyzed; 14.1% had short IPI, 78.6% intermediate, and 7.3% long IPI.
  • Cumulative incidences of cardiovascular morbidity hospitalizations were comparable across all IPI groups.
  • Short and long IPIs were not identified as independent risk factors for pediatric cardiovascular morbidity (aHR 0.97 and 1.01, respectively).

Conclusions:

  • Extreme interpregnancy intervals (short or long) do not appear to significantly impact long-term cardiovascular hospitalizations in offspring.
  • The findings suggest that IPI length may not be a critical determinant of later cardiovascular health in children within this population.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
138
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
347
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
92
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
111
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.4K